Rights and permissions
About this article
Cite this article
IL-2 and tretinoin more cost effective than bevacizumab. Pharmacoecon. Outcomes News 621, 9 (2011). https://doi.org/10.2165/00151234-201106210-00019
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106210-00019